ProQR Therapeutics (PRQR) Cash from Operations (QoQ) (2013 - 2022)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | ProQR Therapeutics | 174.11 Mn | 66.54 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2022 | 7.24% |
| Sep 30, 2022 | 2.20% |
| Jun 30, 2022 | 31.05% |
| Mar 31, 2022 | -630.51% |
| Dec 31, 2021 | 145.57% |
| Sep 30, 2021 | 20.94% |
| Jun 30, 2021 | 15.29% |
| Mar 31, 2021 | -1.21% |
| Dec 31, 2020 | -22.32% |
| Sep 30, 2020 | 0.80% |
| Jun 30, 2020 | -69,623.81% |
| Mar 31, 2020 | 99.87% |
| Dec 31, 2019 | -35.58% |
| Sep 30, 2019 | 20.14% |
| Jun 30, 2019 | 13.02% |
| Mar 31, 2019 | -135,156.03% |
| Dec 31, 2018 | 99.79% |
| Sep 30, 2018 | 23.51% |
| Jun 30, 2018 | -54,264,611.15% |
| Mar 31, 2018 | -99.88% |
| Dec 31, 2017 | 114,681.44% |
| Sep 30, 2017 | 100.00% |
| Jun 30, 2017 | -115,783.67% |
| Mar 31, 2017 | 100.03% |
| Dec 31, 2016 | -306,368.56% |
| Dec 31, 2015 | -380,847.82% |
| Mar 31, 2015 | 4.27% |
| Dec 31, 2014 | -9.10% |
| Mar 31, 2014 | -110.27% |
| Dec 31, 2013 | -22.87% |